CVE-2024-33724: soplanning · Cross-site Scripting
Affects soplanningSource CVE Database V5
Not known to be exploited · public detection template (Nuclei) · CVSS 5.4 Medium.
Data as of 26 Oct 2026, 17:16 UTC
- EPSS
- 0.5% chance of exploitation in 30 days – higher than 45% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 8 May 2026
Detectable: evidence found.
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
GitHubfuzzlove/soplanningpkg:github/fuzzlove/soplanningOther threats | Affected
| Fixed in– |
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
Until an official fix is available, users should exercise caution when interacting with untrusted inputs related to the groupe_id parameter. Implementing web application firewall (WAF) rules to detect and block suspicious input patterns may provide temporary mitigation.
Description
SOPlanning version 1.52.00 contains a Cross Site Scripting (XSS) vulnerability in the groupe_id parameter of the process/groupe_save.php script. This vulnerability allows an attacker to inject malicious scripts that could be executed in the context of a user's browser session. The vulnerability has a CVSS score of 5.4, indicating a medium severity level. No official patch or remediation guidance is currently available from the vendor. There are no known exploits in the wild at this time.